The New State-of-Art OligoPilot 2000 solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.
This is the first time the Agency has authorized the Phase 3 clinical evaluation in the U.S of a microbiota-based live biotherapeutic based on a pooling technology
Fully equipped labs with 75-member team set-up and made operational in <100 days
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
The meeting provides recommendations to the G20 and its Member States and international partners on the establishment of a R&D and manufacturing network for diagnostics
The combination will support clients in getting their end-to-end discovery and development programs delivered.
Study efficacy measures will include the expression of dystrophin protein and motor function.
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
Science communication brings behavioural changes
ProBioGen previously developed the cell line and the manufacturing process and provided the initial clinical material for ImmunOs' innovative biologic.
Subscribe To Our Newsletter & Stay Updated
